19 July 2023, Geneva, Switzerland - The Stop TB Partnership praises the strong leadership shown by Indonesia’s President Joko Widodo and his government after they announced a package of interventions to strengthen their actions to fight Tuberculosis (TB).

A policy brief outlines recommendations for G20 members to act together to accelerate TB vaccine development.

A one-pager, developed by TB Vax ARM, provides relevant background information on the critical need for Member States to substantially increase adequate, predictable, and sustainable financing for TB vaccine research.

Introducing novel tuberculosis (TB) vaccines in lower-and middle-income countries (LMICs) has potential to reduce income-based inequalities in health and economic effects, according to a new study published in BMJ Global Health.

• No other disease in South Africa kills as many people as tuberculosis (TB). To change this, the health department has a new plan for curbing TB infections.

• Until now, only people with HIV and children under five could get preventive medicines. But the new guidelines say anyone who has a big chance of getting infected because they are in contact with someone who has TB, can get the pills.

• Preventive treatment can help to stop infections from spreading, but it needs to be part of a bigger strategy if it is to really get us closer to ending TB.

In 2005, when Busisiwe Beko suspected that she was pregnant, she headed to her local clinic for a test. Beko got more than she bargained for: she tested positive for HIV too.

Global Drug Facility announces an agreement with Johnson & Johnson for access to affordable generic versions of bedaquiline; Treatment Action Group, Médecins Sans Frontières and Partners in Health release statements in response to the agreement.

Advocates demand that Johnson & Johnson commit to non-enforcement of secondary patent on bedaquiline so that access to generic, quality-assured bedaquiline is guaranteed after the primary patent expires on 18 July 2023.

A panel of 65 global experts have identified eight clinical standards for the management of adverse effects during treatment for tuberculosis (TB).

The World Health Organization (WHO) launched two new e-courses on national strategic planning for TB and systematic screening for TB disease. The new WHO e-courses have been added to the End TB Channel in OpenWHO. They are free of charge and self-paced. A certificate can be downloaded if a 80% score or higher is achieved in the final assessment.

The World Health Organization (WHO) Global Tuberculosis Programme has created an online platform to help users find practical advice to implement digital technologies to support TB care worldwide. The platform includes easy access to guidelines and job aids developed by WHO and technical partners, as well as links to key literature and country examples. The content is organized around four functions: person-centred care, programme management, surveillance and monitoring, and eLearning. The online platform will be updated regularly with the most recent guidance and tools.